Morgan Stanley Maintains AbbVie(ABBV.US) With Buy Rating, Maintains Target Price $224

Futu News58minutes ago · Ratings

After experiencing a bumper harvest in 2024, the USA ETF may encounter setbacks this year.

The USA Exchange Traded Fund (ETF) received a record inflow of $1.1 trillion in 2024, but entering 2025, rapid growth may face more obstacles.

Zhitong FinanceJan 2 20:49

Drug-Trial Results Could Shake Up Pharma Stocks in 2025. Watch Eli Lilly, Pfizer, and More. -- Barrons.com

Barron'sJan 1 16:30

AbbVie (ABBV) Upgraded to Buy: What Does It Mean for the Stock?

Zacks Jan 1 00:15

Brokers Suggest Investing in AbbVie (ABBV): Read This Before Placing a Bet

Yahoo FinanceDec 31, 2024 22:30

Is AbbVie Inc. (ABBV) the Best Pharma Dividend Stock to Buy In 2024?

Yahoo FinanceDec 31, 2024 06:17